FXS-5626
N/A
Report date: 2025/12/23 20:00:10
NME
Base Information
Drug NameFXS-5626
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAccro Bioscience (Suzhou) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAccro Bioscience (Suzhou) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A